Not So Different: A Podcast From The Center For Biosimilars
S3 Ep14: Byoungseo Choi on Celltrion's Biosimilar Goals For 2030
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:08:57
- Mais informações
Informações:
Sinopse
To learn more about Celltrion Healthcare, visit celltrionhealthcare.com. You can learn more about the testing of Celltrion's infliximab biosimilar for the treatment of COVID-19 here.
